Could belly fat age our cells faster?
NCT ID NCT01525472
First seen Aug 21, 2026 · Last updated Aug 21, 2026
Summary
This study investigates whether visceral (belly) fat cells age more quickly than other fat tissue in people with severe obesity, and whether that accelerated aging contributes to conditions like diabetes and heart disease. Researchers will analyze fat samples from about 186 adults undergoing bariatric surgery, looking for signs of cellular aging and inflammation. The goal is to better understand how belly fat becomes harmful and to identify potential targets for future treatments.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If the link is confirmed, it could point toward new treatments that slow fat-cell aging and reduce obesity-related diseases like diabetes.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. Results may not lead directly to treatments, and findings might not apply to all people with obesity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
186 people
The number who actually took part.
- Started
-
Feb 2012
- Finished
-
Oct 2015
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
hospital center
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 65 y * Social security insurance * Candidate for bariatric surgery based on criteria established by international experts (BMI\> 40 or\> 35 kg / m² with comorbidities, after failure of multidisciplinary care for a period of at least 1 year) * Patient having signed an informed consent Exclusion criteria * Subject under guardian ship, curator ship or judicial protection. * Subject taking anti-inflammatory and / or non-steroidal drug * Current immunosuppressive therapy or interrupted for less than six months * malignancy or severe inflammatory disease evolving * Positive HIV serology and / or HBV and / or HCV * Current pregnancy * medical or psychiatric contraindication for bariatric surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Morbid obesity are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Louis Mourier
Colombes, 92700, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tailoring bypass length to the individual improve Weight-Loss surgery?
- Can shedding pounds reshape the legs? a study tracks joint alignment after Weight-Loss surgery
- Can shedding weight reshape the spine? a study tracks the changes
- One surgery or two? study tests combining gallbladder removal with Weight-Loss surgery
- Could a simple drug cut bleeding risk in weight-loss surgery?
- Blood test clues could flag Weight-Surgery risks